1. Home
  2. WVE vs INVX Comparison

WVE vs INVX Comparison

Compare WVE & INVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • INVX
  • Stock Information
  • Founded
  • WVE 2012
  • INVX 2024
  • Country
  • WVE Singapore
  • INVX United States
  • Employees
  • WVE N/A
  • INVX N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • INVX
  • Sector
  • WVE Health Care
  • INVX
  • Exchange
  • WVE Nasdaq
  • INVX NYSE
  • Market Cap
  • WVE 915.6M
  • INVX 1.0B
  • IPO Year
  • WVE 2015
  • INVX N/A
  • Fundamental
  • Price
  • WVE $7.22
  • INVX $15.58
  • Analyst Decision
  • WVE Strong Buy
  • INVX Sell
  • Analyst Count
  • WVE 11
  • INVX 1
  • Target Price
  • WVE $20.91
  • INVX $13.00
  • AVG Volume (30 Days)
  • WVE 1.1M
  • INVX 380.7K
  • Earning Date
  • WVE 05-08-2025
  • INVX 05-06-2025
  • Dividend Yield
  • WVE N/A
  • INVX N/A
  • EPS Growth
  • WVE N/A
  • INVX 19.36
  • EPS
  • WVE N/A
  • INVX 2.31
  • Revenue
  • WVE $104,939,000.00
  • INVX $773,221,000.00
  • Revenue This Year
  • WVE N/A
  • INVX $39.85
  • Revenue Next Year
  • WVE N/A
  • INVX $0.72
  • P/E Ratio
  • WVE N/A
  • INVX $6.79
  • Revenue Growth
  • WVE N/A
  • INVX 42.69
  • 52 Week Low
  • WVE $4.25
  • INVX $11.93
  • 52 Week High
  • WVE $16.74
  • INVX $19.42
  • Technical
  • Relative Strength Index (RSI)
  • WVE 61.17
  • INVX N/A
  • Support Level
  • WVE $5.98
  • INVX N/A
  • Resistance Level
  • WVE $6.30
  • INVX N/A
  • Average True Range (ATR)
  • WVE 0.33
  • INVX 0.00
  • MACD
  • WVE 0.14
  • INVX 0.00
  • Stochastic Oscillator
  • WVE 92.21
  • INVX 0.00

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About INVX INNOVEX INTERNATIONAL INC

Innovex International Inc designs, manufactures, sells, and rents mission-critical engineered products to the oil and natural gas industry. Its products are Subsea, Surface Wellheads, Well Construction, Well Completion, Production Solutions, Fishing & Intervention. Its products support upstream onshore and offshore activities. The group's geographic regions are North America, Latin America, Middle East & Asia Pacific, and Europe & Africa.

Share on Social Networks: